1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.01. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.01.2025 | 422 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 20.01.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.01.2025ISIN NameAU000000CAI2 CALIDUS... ► Artikel lesen | |
| 14.01. | Nasdaq Stockholm AB: Delisting of Ziccum AB from Nasdaq First North Growth Market | 360 | GlobeNewswire | On January 10, 2025, Ziccum AB was declared bankrupt by Lund District Court.
According to item 8.2.7 of the Nasdaq First North Growth Market Rulebook, the exchange may decide to delist the financial... ► Artikel lesen | |
| 10.01. | XFRA 7IZ: AUSSETZUNG/SUSPENSION | 321 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZICCUM AB 7IZ SE0011415595... ► Artikel lesen | |
| 10.01. | Ziccum AB: Ziccum AB (publ) files for bankruptcy | 278 | GlobeNewswire (Europe) | The board of directors of Ziccum AB (publ) ("Ziccum"or the "Company") has today, 10 January 2025, resolved to file for bankruptcy on behalf of the Company to manage the financial situation that has... ► Artikel lesen | |
| 25.11.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Ziccum AB (publ) | 314 | GlobeNewswire | With effect from November 26, 2024, the unit rights in Ziccum AB (publ) will be
traded on First North Growth Market. Trading will continue up until and
including December 05, 2024.
Instrument: Unit... ► Artikel lesen | |
| 20.11.24 | Ziccum AB: Ziccum publishes prospectus due to upcoming rights issue | 249 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 20.11.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 20.11.2024 | 553 | Xetra Newsboard | Das Instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC ETF wird cum Kapitalmassnahme gehandelt am 20.11.2024 und ex Kapitalmassnahme am 21.11.2024 The instrument M7ES IE000K6PPGX7 HANETF-SPR.EN.TRA.MT.EOAC... ► Artikel lesen | |
| ZICCUM Aktie jetzt für 0€ handeln | |||||
| 29.10.24 | Ziccum AB: Ziccum AB (publ) Interim report Q3 2024 | 153 | GlobeNewswire (Europe) | INTERIM REPORT Q3, 1 JULY - 30 SEPTEMBER 2024
Significant events after Q3 2024Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loanOn October 10, The Board... ► Artikel lesen | |
| 10.10.24 | Ziccum AB: Ziccum intends to resolve on a rights issue of approximately SEK 30 million and raises a bridge loan | 182 | GlobeNewswire (Europe) | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 30.08.24 | Ziccum AB: Ziccum AB (publ) Interim report Q2 2024 | 238 | GlobeNewswire (Europe) | INTERIM REPORT Q2, 1 JANUARY - 30 JUNE 2024
Significant events during Q2 2024Ziccum strengthens and streamlines business and finance functionsOn April 3, the company announced that it is reorganizing... ► Artikel lesen |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,520 | +1,80 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,850 | +1,45 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| THERMO FISHER | 361,85 | -0,44 % | Cybin taps Thermo Fisher for potential commercial manufacturing of CYB003 | ||
| EUROFINS SCIENTIFIC | 56,04 | +2,98 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each... ► Artikel lesen | |
| SYNLAB | 12,940 | +0,47 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| DAVITA | 124,95 | -0,24 % | DaVita Inc. Reveals Retreat In Q1 Profit | WASHINGTON (dpa-AFX) - DaVita Inc. (DVA) reported a profit for first quarter that decreased from the same period last yearThe company's bottom line totaled $162.92 million, or $2.00 per share.... ► Artikel lesen | |
| DENTSPLY SIRONA | 14,750 | +0,10 % | Dentsply Sirona Inc Q1 Profit Increases, Beats Estimates | YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc (XRAY) reported earnings for its first quarter that increased from last year and beat the Street estimates.The company's earnings came in... ► Artikel lesen | |
| SMITH & NEPHEW | 12,755 | +0,83 % | Smith & Nephew UK Ltd: A comparative sNPWT study of 10,000+ C-sections shows PICO sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices... ► Artikel lesen | |
| SONIC HEALTHCARE | 15,052 | -0,15 % | Sonic Healthcare shares are down more than 40% since 2021. Will its AI initiative be the catalyst for a turnaround? | ||
| DIASORIN | 93,92 | -0,82 % | Milan: Downbeat day for DiaSorin | ||
| PATTERSON COMPANIES | 27,400 | 0,00 % | Patterson Companies Completes Acquisition by Patient Square Capital | Robert Rajalingam Appointed Chief Executive Officer and to Board of Directors
ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies ("Patterson" or the "Company"), a leading supplier of products... ► Artikel lesen | |
| FULGENT GENETICS | 17,500 | -0,57 % | Fulgent genetics targets $310M core revenue in 2025 with strong growth in diagnostics and pathology | ||
| IMPLANTICA | 2,930 | -7,86 % | Bulletin from the Annual General Meeting of Implantica AG | VADUZ, Liechtenstein, May 15, 2025 /PRNewswire/ -- Today, May 15, 2025, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,910 | -1,55 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results | First of several clinical updates through mid-2026 accepted for presentation at the 2025 American Society of Clinical Oncology Annual Meeting, with recruitment progressing for all three of our clinical... ► Artikel lesen | |
| OMNICELL | 25,800 | 0,00 % | Omnicell's New Perioperative Clinic Setting Products May Boost Stock |
ZICCUM AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,001 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZICCUM AB finden Sie auf Wallstreet Online.